ClinicalTrials.govpublic full text
Angiogenic and EGFR Blockade With Curative Chemoradiation for Advanced Head and Neck Cancer
head and neck cancer, pharynx cancer, targeted therapy, bevacizumab, erlotinib, tarceva, radiotherapy, concurrent chemotherapy, tonsil cancer, hyperfractionation, angiogenesis, epidermal growth factor
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 846130
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.